Abstract
Ivabradine is the first selective sinus node inhibitor for use in the treatment of angina. In this article Dr Doig describes its novel mode of action and the results of clinical trials of its efficacy and safety. Copyright © 2006 Wiley Interface Ltd
Cite
CITATION STYLE
APA
Doig, C. (2006). Ivabradine: first of a new class of treatments for angina. Prescriber, 17(15), 14–17. https://doi.org/10.1002/psb.404
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free